Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 52.00
-0.30 (-0.57%)
Aug 19, 2026, 1:30 PM CST
Formosa Laboratories Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,640 | 4,851 | 4,731 | 4,360 | 3,766 | 3,142 | |
Revenue Growth | -2.71% | 2.54% | 8.50% | 15.80% | 19.83% | 2.18% |
Cost of Revenue | 2,715 | 2,819 | 2,682 | 2,437 | 2,375 | 2,171 |
Gross Profit | 1,925 | 2,032 | 2,049 | 1,923 | 1,390 | 971.44 |
Selling, General & Admin | 506.22 | 510.08 | 502.26 | 432.95 | 421.34 | 453.14 |
Research & Development | 754.01 | 727.91 | 796.42 | 841.87 | 777.02 | 700.2 |
Operating Expenses | 1,255 | 1,229 | 1,323 | 1,248 | 1,227 | 1,139 |
Operating Income | 670.24 | 803.18 | 725.9 | 674.98 | 163.49 | -168.02 |
Interest Expense | -25.32 | -33.12 | -39.61 | -34.74 | -19.32 | -28.05 |
Interest & Investment Income | 29.06 | 32.26 | 32.24 | 23.71 | 2.14 | 0.36 |
Earnings From Equity Investments | 4.8 | 8.71 | -2.16 | 5.56 | 7.59 | 9.17 |
Currency Exchange Gain (Loss) | -163.09 | -163.09 | 25.98 | -65.78 | 10.38 | -6.86 |
Other Non Operating Income (Expenses) | 165.92 | 35.55 | 7.38 | 2 | 168.82 | 1,318 |
EBT Excluding Unusual Items | 681.61 | 683.48 | 749.71 | 605.73 | 333.11 | 1,124 |
Gain (Loss) on Sale of Investments | -181.82 | -181.82 | -523.05 | -428.92 | - | - |
Gain (Loss) on Sale of Assets | 0.09 | 0.09 | -21.61 | 0.09 | 0.05 | 0.11 |
Other Unusual Items | 0.01 | 0.01 | -6.9 | -34.51 | 0.02 | -36.9 |
Pretax Income | 499.88 | 501.75 | 198.15 | 142.39 | 333.18 | 1,088 |
Income Tax Expense | 114.52 | 105.72 | 134.08 | 194.65 | 116.37 | 44.01 |
Earnings From Continuing Operations | 385.36 | 396.03 | 64.08 | -52.26 | 216.81 | 1,044 |
Minority Interest in Earnings | 90.34 | 45.08 | 93.19 | 178.5 | 192.55 | 205.58 |
Net Income | 475.7 | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 |
Net Income to Common | 475.7 | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 |
Net Income Growth | - | 180.48% | 24.58% | -69.16% | -67.23% | 212.25% |
Shares Outstanding (Basic) | 113 | 120 | 120 | 120 | 120 | 114 |
Shares Outstanding (Diluted) | 114 | 121 | 121 | 120 | 121 | 121 |
Shares Change | -5.13% | 0.24% | 0.41% | -0.33% | -0.51% | 2.79% |
EPS (Basic) | 4.21 | 3.67 | 1.31 | 1.05 | 3.40 | 10.92 |
EPS (Diluted) | 4.17 | 3.64 | 1.30 | 1.05 | 3.39 | 10.32 |
EPS Growth | - | 180.00% | 23.84% | -69.03% | -67.14% | 198.32% |
Free Cash Flow | -350.81 | 518.17 | 140.38 | 288.07 | 204.66 | -197.62 |
Free Cash Flow Per Share | -3.08 | 4.27 | 1.16 | 2.39 | 1.69 | -1.63 |
Dividend Per Share | - | 3.000 | 3.000 | 2.000 | 1.000 | 2.000 |
Dividend Growth | - | 0% | 50.00% | 100.00% | -50.00% | - |
Gross Margin | 41.49% | 41.89% | 43.30% | 44.11% | 36.92% | 30.91% |
Operating Margin | 14.45% | 16.56% | 15.34% | 15.48% | 4.34% | -5.35% |
Profit Margin | 10.25% | 9.09% | 3.32% | 2.90% | 10.87% | 39.75% |
Free Cash Flow Margin | -7.56% | 10.68% | 2.97% | 6.61% | 5.44% | -6.29% |
EBITDA | 1,224 | 1,344 | 1,225 | 1,155 | 595.07 | 296.59 |
EBITDA Margin | 26.39% | 27.70% | 25.90% | 26.49% | 15.80% | 9.44% |
D&A For EBITDA | 554.26 | 540.86 | 499.35 | 479.96 | 431.58 | 464.61 |
EBIT | 670.24 | 803.18 | 725.9 | 674.98 | 163.49 | -168.02 |
EBIT Margin | 14.45% | 16.56% | 15.34% | 15.48% | 4.34% | -5.35% |
Effective Tax Rate | 22.91% | 21.07% | 67.66% | 136.70% | 34.93% | 4.05% |